• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对喉、咽和口腔鳞状细胞癌进行根治性治疗的患者进行常规长期随访。这有意义吗?

Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense?

作者信息

de Visscher A V, Manni J J

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Nijmegen, The Netherlands.

出版信息

Arch Otolaryngol Head Neck Surg. 1994 Sep;120(9):934-9. doi: 10.1001/archotol.1994.01880330022005.

DOI:10.1001/archotol.1994.01880330022005
PMID:8074820
Abstract

OBJECTIVE

To evaluate whether additional curative treatment was possible in patients for whom routine long-term follow-up had led to the early detection of locoregional recurrence, distant metastases, and second primary tumors (events).

DESIGN

Cohort study with a maximum follow-up of 126 months and a consensus questionnaire.

SETTING

Department of Head and Neck Oncology at the University Hospital Nijmegen (the Netherlands).

PATIENTS

There were 428 patients treated with curative intent for carcinoma of the larynx, pharynx, and oral cavity from 1979 to 1983.

MAIN OUTCOME MEASURES

Site, stage, differentiation grade, and type of treatment of index tumor (routine follow-up vs self-referral).

RESULTS

There were 205 patients (47.9%) who developed events, 76.1% within 3 years of initial treatment. Eighty-nine patients (43.4%) received curative treatment. The detection rate for events during routine follow-up (6350 appointments) was one in 34, and for self-referrals (54) it was one in 2.7; the cure rates were one in 78 and one in 6.8, respectively. The mean survival after detection of events with routine follow-up was significantly (P < .05) better than with self-referral (58 vs 32 months, respectively).

CONCLUSIONS

Routine follow-up is indispensible. Site and stage of the index tumor played a part in the length of routine follow-up, in contrast to the differentiation grade or type of initial treatment. Yearly chest roentgenograms were valuable only for laryngeal index tumors. Patients considered routine follow-up important; however, negative findings at physical examination of complaints did not reassure all patients.

摘要

目的

评估对于那些经常规长期随访早期发现局部区域复发、远处转移和第二原发性肿瘤(事件)的患者,是否有可能进行额外的根治性治疗。

设计

队列研究,最长随访126个月,并采用共识问卷。

地点

荷兰奈梅亨大学医学中心头颈肿瘤学系。

患者

1979年至1983年期间,428例接受喉、咽和口腔癌根治性治疗的患者。

主要观察指标

原发肿瘤的部位、分期、分化程度和治疗类型(常规随访与自行转诊)。

结果

205例患者(47.9%)发生了事件,76.1%发生在初始治疗的3年内。89例患者(43.4%)接受了根治性治疗。常规随访期间(6350次预约)事件的检出率为1/34,自行转诊(54次)的检出率为1/2.7;治愈率分别为1/78和1/6.8。常规随访发现事件后的平均生存期显著优于自行转诊(分别为58个月和32个月,P<0.05)。

结论

常规随访必不可少。原发肿瘤的部位和分期对常规随访的时长有影响,而分化程度或初始治疗类型则不然。每年的胸部X线检查仅对喉原发肿瘤有价值。患者认为常规随访很重要;然而,体格检查无异常发现并不能让所有患者放心。

相似文献

1
Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense?对喉、咽和口腔鳞状细胞癌进行根治性治疗的患者进行常规长期随访。这有意义吗?
Arch Otolaryngol Head Neck Surg. 1994 Sep;120(9):934-9. doi: 10.1001/archotol.1994.01880330022005.
2
[Consumption and value of regular after care by patients with squamous cell carcinomas of the larynx, mouth cavity and pharynx].[喉、口腔和下咽鳞状细胞癌患者定期后续护理的消耗及价值]
HNO. 1988 Jan;36(1):28-32.
3
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.喉和下咽鳞状细胞癌的区域转移延迟、远处转移及第二原发性恶性肿瘤
Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028.
4
Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".头颈部鳞状细胞癌患者的术后(化疗)放疗——来自临床合作组“头颈部癌症个体化放疗”队列的临床结果。
Radiat Oncol. 2018 Jul 3;13(1):123. doi: 10.1186/s13014-018-1067-1.
5
Effectiveness of routine follow-up of patients treated for T1-2N0 oral squamous cell carcinomas of the floor of mouth and tongue.口腔底部和舌部T1-2N0期口腔鳞状细胞癌患者常规随访的有效性
Head Neck. 2006 Jan;28(1):1-7. doi: 10.1002/hed.20296.
6
[Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings].[口腔、咽及喉癌中的第二原发癌。临床、组织病理学及细胞动力学研究结果]
Laryngorhinootologie. 2000 Aug;79(8):478-82. doi: 10.1055/s-2000-5908.
7
Analysis of treatment results for floor-of-mouth cancer.口腔底部癌的治疗结果分析
Laryngoscope. 2000 Oct;110(10 Pt 1):1764-72. doi: 10.1097/00005537-200010000-00038.
8
Management of stage IV glottic carcinoma: therapeutic outcomes.IV期声门癌的治疗:治疗结果
Laryngoscope. 2004 Aug;114(8):1438-46. doi: 10.1097/00005537-200408000-00024.
9
[Malignancies of the mouth cavity, pharynx and larynx--symptoms, diagnosis and therapy].[口腔、咽和喉恶性肿瘤——症状、诊断与治疗]
Ther Umsch. 1998 Jul;55(7):449-52.
10
Changing patterns of failure of head and neck cancer.头颈癌失败模式的变化
Arch Otolaryngol Head Neck Surg. 2002 Mar;128(3):324-7. doi: 10.1001/archotol.128.3.324.

引用本文的文献

1
Diagnostic value of MRI for posttreatment surveillance of early-stage (I-II) glottic larynx cancer.MRI对早期(I-II期)声门型喉癌治疗后监测的诊断价值。
Strahlenther Onkol. 2025 Sep 2. doi: 10.1007/s00066-025-02460-6.
2
DeintensiF: Standard versus individualized deintensified follow-up after curative treatment in head and neck cancer: protocol of a randomized pilot study.DeintensiF:头颈部癌根治性治疗后标准与个体化减强度随访:一项随机试点研究方案
Pilot Feasibility Stud. 2025 May 16;11(1):69. doi: 10.1186/s40814-025-01651-3.
3
Comparison of surveillance modalities in the surveillance of sinonasal squamous cell carcinoma recurrence: A multi-institutional study.
鼻窦鳞状细胞癌复发监测中监测方式的比较:一项多机构研究。
Int Forum Allergy Rhinol. 2025 Apr;15(4):384-394. doi: 10.1002/alr.23495. Epub 2024 Dec 3.
4
Contrast-Enhanced Computed Tomography (CT) With Concordant Sonography as Sufficient Early Detection Tools for Recurrent and Persistent Cervical Metastases After (Chemo)radiotherapy (CRT).对比增强计算机断层扫描(CT)联合超声检查作为(化疗)放疗(CRT)后复发性和持续性颈部转移的充分早期检测工具。
Head Neck. 2025 Mar;47(3):999-1005. doi: 10.1002/hed.28008. Epub 2024 Nov 19.
5
PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial.PET-CT 引导、基于症状、患者发起的头颈部癌症患者监测与临床随访(PETNECK2):一项多中心可行性研究和非劣效性、随机、III 期试验的研究方案。
BMC Cancer. 2024 Jul 10;24(1):823. doi: 10.1186/s12885-024-12470-9.
6
[Acceptance of digital apps in the follow-up of patients with head and neck tumors].[数字应用在头颈部肿瘤患者随访中的应用]
HNO. 2025 Feb;73(2):122-128. doi: 10.1007/s00106-024-01463-6. Epub 2024 May 3.
7
PET/CT Imaging in Treatment Planning and Surveillance of Sinonasal Neoplasms.PET/CT成像在鼻窦肿瘤治疗计划与监测中的应用
Cancers (Basel). 2023 Jul 25;15(15):3759. doi: 10.3390/cancers15153759.
8
Factors associated with loss to follow-up after radiation therapy for head and neck cancer.头颈部癌症放射治疗后随访丢失的相关因素。
Head Neck. 2022 Apr;44(4):943-951. doi: 10.1002/hed.26986. Epub 2022 Jan 25.
9
Less Is More? The Association between Survival and Follow-Up Protocol after Treatment in Oral Cavity Cancer Patients from a Betel Quid-Prevalent Region.少即是多?咀嚼槟榔流行地区口腔癌患者治疗后生存与随访方案的相关性研究。
Int J Environ Res Public Health. 2021 Nov 29;18(23):12596. doi: 10.3390/ijerph182312596.
10
Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial.临床医生对头颈癌患者主动随访的看法:一项定性研究,为 PETNECK2 试验提供信息。
Clin Oncol (R Coll Radiol). 2022 Apr;34(4):230-240. doi: 10.1016/j.clon.2021.11.010. Epub 2021 Dec 1.